Products for Research Use Only
RegisterLogin

AM-1430

CAT: 0804-HY-115814Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-115814Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
AM-1430 is an efficient, highly selective and orally active small molecule inhibitor of PI3Kδ with an IC50 of 4.6 nM. AM-1430 exhibits IC50s for PI3Kα, PI3Kβ and PI3Kγ of 14.18, 2.2 and 3.22 μM, respectively. AM-1430 inhibits B cell proliferation and exhibits excellent in vivo activity in pAKT inhibition models and the hemoglobin (KLH) immune response model. AM-1430 can be used for the study of inflammation and autoimmune diseases[1].
CAS Number
1975263-74-1
UNSPSC
12352005
Target
PI3K
Related Pathways
PI3K/Akt/mTOR
Field of Research
Inflammation/Immunology
Smiles
CNC(C1=C(C([C@@H](NC2=NC=NC(N)=C2C#N)C)=NC3=CC=CC(F)=C13)C4=NC=CC=C4)=O
Molecular Formula
C23H19FN8O
Molecular Weight
442.45
References & Citations
[1]Gonzalez-Lopez de Turiso F, et al. Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2- ((1S) -1- ((6-Amino-5-cyano-4-pyrimidinyl) amino) ethyl) -6-fluoro-N-methyl-3- (2-pyridinyl) -4-quinolinecarboxamide (AM-0687) and 2- ((1S) -1- ((6-Amino-5-cyano-4-pyrimidinyl) amino) ethyl) -5-fluoro-N-methyl-3- (2-pyridinyl) -4-quinolinecarboxamide (AM-1430) . J Med Chem. 2016 Aug 11;59 (15) :7252-67.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ

Related Products

CatalogName
HY-126558-01GA3-AM
HY-118374AM-9635
HY-135495AM-0466
HY-108329-01AM-0902
HY-137103BTC-AM
HY-12941AM-7209
HY-122007AM-0561
HY-120493AAM-6226
HY-12585-01AM-4668
HY-W010756-01FMOC-AM

Alternative Products

CatalogName
MBS5776335AM-1430
110042Hsp-1430
2332330AE-1430 EzApply
S0B1189-01PIAS1 Recombinant Rabbit mAb (S-1430-7)
BA5219-5.1AM-6538
BA6990-5.1AM-2099
B7392-100AM 1172
B5370-1BCECF-AM
BA5327-5AM-1638
B4758-5.1BAPTA-AM

Popular Products